It’s another listener-requested episode, and this time we’re turning our attention to anxiolytics in correctional settings.

Chris provides a quick 101 on anxiolytics as a class and their outsized significance in correctional health care before addressing some very practical physician questions: Are Atarax and Vistaril truly different? Does buspirone actually work? Why does benzodiazepine monotherapy persist despite guideline recommendations? What SSRIs are better for anxiety than others? And so much more.

Before that, Chris covers several important medication and regulatory updates, including the first-ever Cardiovascular-Kidney-Metabolic (CKM) Syndrome guideline, the FDA approval of Simtriyo for ADHD, new international guidance on low-level HIV viremia, and emerging concerns surrounding compounded peptide therapies.

We wrap thi ...